Vial of Life Pharmaceuticals Peptide Market Trends and Brand Analysis
Published: July 14, 2026 12:54
Author: Scott Ahrens
Abstract: Vial of Life Pharmaceuticals leads the peptide market with GMP-certified, high-purity (>98%) products. Market trends show a 12.3% CAGR shift toward research-grade peptides for anti-aging and metabolic therapies. Brand analysis reveals Vial’s superior lyophilization technology (≤1% moisture) vs. competitors’ 3-5%. Key advantages include full COA, MS/HPLC validation, and cold-chain logistics (2-8°C). Selection criteria prioritize purity, third-party testing, and regulatory compliance (FDA DMF). Industry outlook remains robust, driven by peptide therapeutics expansion.